iganidipine

04/01/1998 - "Nonhemodynamic effects of iganidipine may be partly involved in its protective effects against arterial injuries."
04/01/1998 - "CONCLUSIONS: In Dahl-S rats fed an HSD, iganidipine completely prevented all the changes at a sustained-hypotensive dose and prevented the injuries of PMA and aortic endothelium and the reduction of EDR in the aorta at a nonsustained hypotensive dose. "
04/01/1998 - "Iganidipine at 1 mg/kg/day, which lowered blood pressure only for several hours, decreased the injuries in PMA and aortic endothelium and moderately restored the EDR in the aorta. "
08/01/1997 - "In conclusion, iganidipine prevented renal and cerebral injuries in Dahl-S rats. "
08/01/1997 - "Iganidipine reduced glomerulosclerosis and renal arterial and tubular injuries in a dose-dependent manner. "

04/01/2005 - "Coadministration of iganidipine had no significant effect on NMDA-induced thinning of the inner plexiform layer but partly suppressed KA-induced thinning at final intravitreous concentrations of 10(-8) M or higher, which was confirmed by counting the ganglion cell number. "

10/01/2009 - "Calcium channel-blockers such as lomerizine do not seem to affect systemic hypotension, while topical calcium-blockers like flunarizine and iganidipine are also under research. "

08/01/1997 - "Preventive effect of iganidipine on renal and cerebral injuries in salt-induced hypertension."

08/01/1997 - "Iganidipine also reduced the incidence of cerebral infarction. "